XENEXenon Pharmaceuticals Inc.

$5B

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$9M

Operating Income

-$12M

Net Income

-$11M

EPS (Diluted)

$-0.44

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$491,000

Balance Sheet

Total Assets

$115M

Total Liabilities

$22M

Stockholders' Equity

$92M

Cash & Equivalents

$52M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$9M	-$6M	-64.1%
Operating Income	-$12M	-$8M	-50.4%
Net Income	-$11M	-$4M	-202.0%

XENE Q1 2019 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena